Murff, Harvey J. http://orcid.org/0000-0002-4943-4665
Greevy, Robert A.
Sanghani, Reesha S.
Hartmann, Katherine E.
Hartert, Tina V.
Graves, Cornelia R.
Lee, Scott S.
Tindle, Hilary A.
Funding for this research was provided by:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD09719)
Article History
Received: 18 May 2021
Accepted: 23 November 2021
First Online: 14 December 2021
Declarations
:
: We will have full transparency in reporting experimental details so that others may reproduce and extend the findings. This study protocol was approved by the Vanderbilt University Medical Center (VUMC) Institutional Review Board and is registered with the National Institutes of Health Clinical Trials Registry (NCT04417595).
: We are willing to provide a copy of the informed consent form on request.
: HAT has been the principal investigator of NIH-supported studies for smoking cessation in which the medication was donated by the manufacturer and has volunteered without pay as part of a scientific advisory panel providing design input for a phase 3 trial of cytisine, a medication for smoking cessation which is not yet FDA approved. The other investigators have no competing interests to declare.